SCHEMBL20161052

SCHEMBL20161052

Brc1ccc(-c2c(-c3ccc(Br)cc3)c(-c3ccccc3)c(-n3c4ccccc4c4ccccc43)c(-c3ccc(Br)cc3)c2-c2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
MAPK1 P28482 2/20 0.47
KDM4E B2RXH2 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
ATM Q13315 1/20 0.42
KMT2A Q03164 1/20 0.40
CYP1A1 P04798 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP1B1 Q16678 1/20 0.37
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36
PTGS2 P35354 4/20 0.35
MAPK13 O15264 1/20 0.35
GCGR P47871 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20160994 1.00 ALDH1A1 (0.47) ALDH1A1MAPK1KDM4EL3MBTL1ATM
SCHEMBL20161053 0.89 ALDH1A1 (0.40) ALDH1A1MAPK1KDM4EL3MBTL1ATM
SCHEMBL20161111 0.89 ALDH1A1 (0.40) ALDH1A1MAPK1KDM4EL3MBTL1ATM
SCHEMBL3326442 0.89 KDM4E (0.52) ALDH1A1KDM4EL3MBTL1ATMKMT2A
SCHEMBL10029967 0.87 KDM4E (0.50) ALDH1A1KDM4EL3MBTL1ATMKMT2A
SCHEMBL14701623 0.84 L3MBTL1 (0.59) ALDH1A1MAPK1KDM4EL3MBTL1ATM
SCHEMBL3329259 0.83 DCLK1 (0.42) ALDH1A1MAPK1KDM4EL3MBTL1ATM
SCHEMBL20161195 0.81 L3MBTL1 (0.44) ALDH1A1KDM4EL3MBTL1ATMKMT2A
SCHEMBL12258328 0.77 KDM4E (0.52) ALDH1A1KDM4EL3MBTL1ATMKMT2A
SCHEMBL13777185 0.77 MAPK1 (0.64) ALDH1A1MAPK1KDM4EL3MBTL1CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230354701-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP MERCK PATENT GMBH (DE) 2023-11-02 US disclosed
US-20230354701-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP MERCK PATENT GMBH (DE) 2023-11-02 US disclosed
EP-4271163-A2 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP Merck Patent GmbH (DE) 2023-11-01 EP disclosed
US-11711976-B2 Compounds with an acceptor and a donor group MERCK PATENT GMBH (DE) 2023-07-25 US disclosed
US-11711976-B2 Compounds with an acceptor and a donor group MERCK PATENT GMBH (DE) 2023-07-25 US disclosed
WO-2018087346-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP MERCK PATENT GMBH (DE) 2018-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11711976-B2 Compounds with an acceptor and a donor group NQO1, ICMT, NUDT1 ALDH1A1 242/4885MAPK1 3949/4885KDM4E 2457/4885
US-20230354701-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP NQO1, ICMT, NUDT1 ALDH1A1 242/4885MAPK1 3949/4885KDM4E 2457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.